axsome.com
US medical affairs
This website is intended for US healthcare professionals only.

congress
presentations

29th Nevada Psychiatric Association National Psychopharmacology Update

Las Vegas, NV
February 14-17, 2024

PDF screenshot

AXS-05 | Major Depressive Disorder

Efficacy, Tolerability, and Safety of AXS-05, a Novel Oral Antidepressant: Data from 3 Clinical Trials
view/download
PDF screenshot

AXS-05 | Major Depressive Disorder

Impact of AXS-05, an Oral NMDA Receptor Antagonist, on Anhedonic Symptoms in Major Depressive Disorder
view/download